Mineralys Therapeutics
About:
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Website: http://www.mineralystx.com
Twitter/X: mineralystx
Top Investors: Andera Partners, OrbiMed, RA Capital Management, RTW Investments, Adams Street Partners
Description:
Mineralys Therapeutics is a biopharmaceutical company that provides hypertension treatment. They also bring a targeted approach to the management of hypertension.
Total Funding Amount:
$278M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Radnor, Pennsylvania, United States
Founded Date:
2020-01-01
Founders:
BT Slingsby
Number of Employees:
11-50
Last Funding Date:
2024-02-08
IPO Status:
Public
Industries:
© 2025 bioDAO.ai